Business Description
Canntab Therapeutics Ltd
NAICS : 325412
SIC : 3741
ISIN : CA1377991023
Compare
Compare
Traded in other countries / regions
PILL.CanadaTBF1.GermanyCTABF.USA IPO Date
2011-04-21Description
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -66.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -1885.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Canntab Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.075 | ||
| EPS (TTM) (C$) | -0.09 | ||
| Beta | 0 | ||
| Volatility % | 57.52 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (C$) | 0 | ||
| 20-Day SMA (C$) | 0.005 | ||
| 12-1 Month Momentum % | -66.67 | ||
| 52-Week Range (C$) | 0.005 - 0.02 | ||
| Shares Outstanding (Mil) | 38.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Canntab Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Canntab Therapeutics Ltd Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Canntab Therapeutics Ltd Frequently Asked Questions
What is Canntab Therapeutics Ltd(XCNQ:PILL)'s stock price today?
The current price of XCNQ:PILL is C$0.01. The 52 week high of XCNQ:PILL is C$0.02 and 52 week low is C$0.01.
When is next earnings date of Canntab Therapeutics Ltd(XCNQ:PILL)?
The next earnings date of Canntab Therapeutics Ltd(XCNQ:PILL) is .
Does Canntab Therapeutics Ltd(XCNQ:PILL) pay dividends? If so, how much?
Canntab Therapeutics Ltd(XCNQ:PILL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers